Loading the records…
Loading the records…
Defense Health Agency · DEFENSE HEALTH AGENCY
Defense Health Agency wants bids for "TRICARE Medicare Eligible Program Second Generation (TMEP2)". The work is in USA. Bids are due Dec 4, 2026. In the last 2 years, similar work (matched on the agency only, a loose match) went to 10 or more companies, usually for about $260K per award. An award is expected around December 2026.
Put together from the facts on this page; the details and sources are below.
Your briefs and their views: My briefs.
Every notice posted under solicitation HT940226R0001 in this department, oldest first.
Standard steps for the notice type; not advice about this buyer.
409 award notices on SAM.gov in the last 24 months. Matched by: Same agency (Defense Health Agency), any industry: a loose match.
Loose match: same agency, any industry. Read the titles before treating these as competitors.
Single-winner award sizes (395): middle half $82K to $1.3M, median $260K; range $14K to $1.6B.
| Winner | Awards | Value | Last |
|---|---|---|---|
| REES SCIENTIFIC CORPORATION | 5 | $1.9M | Sep 18, 2026 |
| STERIS CORPORATION · $STE · $6.2B | 4 | $3.6M | Oct 28, 2026 |
| BCG FEDERAL CORP. | 3 | $138.5M | May 27, 2026 |
| A-DEC INC | 3 | $4.9M | Oct 14, 2026 |
| AGILENT TECHNOLOGIES INC · $A · $7.4B | 3 | $2.4M | Oct 6, 2026 |
| O R ELDER INC | 3 | $2.0M | Aug 11, 2026 |
| WERFEN USA LLC | 3 | $666K | Aug 19, 2026 |
| G4S SECURITY SYSTEMS GUAM INC | 3 | $322K | Jul 22, 2026 |
| SIRTEX MEDICAL INC | 3 | $237K | Oct 29, 2026 |
| OptumServe Health Services, Inc. | 2 | $2.7B | Apr 16, 2026 |
Value counts new single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling (same contract, or the same office, day and amount); that ceiling is not one company's win, so it is not added in. Contract modifications are not new awards and are not added in either. Notices whose amount is a placeholder such as $999,999,999 are not added in. Revenue next to a ticker is the company's revenue over the latest 12 months in its SEC filings.
One award's total value against one year of revenue; many awards are paid over several years.
Materiality: one award's value as a share of the winner's revenue over the latest 12 months in its SEC filings (or its last fiscal year, as noted when you point at it). Low under 1%, Medium 1 to 5%, High 5% or more. Many awards are paid over several years, so this overstates a single year's share.
For the 8 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.
None of these past winners filed lobbying reports naming Defense, Dept of (DOD) or Office of the Secretary of Defense or Joint Chiefs of Staff since 2024. No sign of an incumbent lobbying push at this agency.
No lobbyist on these filings lists a past Defense, Dept of (DOD) or Office of the Secretary of Defense or Joint Chiefs of Staff job: no revolving-door tie found in these filings. (These are lobbyists the companies pay, not their own staff.)
Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.
No bills named on these filings under Defense Health Agency-related issues.
A bill's title is shown only when the filing's own text names it; filings often cite last Congress's bill numbers.
No executive order in the last 12 months names Defense Health Agency in its title or summary.
For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.
Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.
Companies are matched to tickers by exact name, including the subsidiaries a company lists in its SEC filings. A company we could not match shows no market rows; that is a miss, not a finding.